CEVR analyzes the benefits, risks, and costs of strategies to improve health and health care.

Little consistency in evidence cited by commercial plans for specialty drug coverage

Health Affairs

Chambers JD, Panzer AD, Pope EF, Graff JS, Neumann PJ. Little consistency in evidence cited by commercial plans for specialty drug coverage. Health Affairs 2019;38(11):1882–6.

Comparative modeling to inform health policy decisions: A step forward

Annals of Internal Medicine Editorial

Kim DD, Neumann PJ. "Comparative modeling to inform health policy decisions: A step forward," Annals of Internal Medicine Editorial," November 4, 2019.

Influence of modeling choices on value of information analysis: An empirical analysis from a real-world experiment

PharmacoEconomics

Kim DD, Guzauskas GF, Bennette CS, Basu A, Veenstra DL, Ramsey SD, Carlson JJ. Influence of modeling choices on value of information analysis: An empirical analysis from a real-world experiment. PharmacoEconomics 2019;:1–9.

Variation in US private health plans’ coverage of orphan drugs

The American Journal of Managed Care

Chambers JD, Panzer AD, Kim DD, Margaretos NM, Neumann PJ. Variation in US private health plans’ coverage of orphan drugs. The American Journal of Managed Care. 2019;25(10):508-512.

Cost-effectiveness of nutrition policies to discourage processed meat consumption: Implications for cancer burden in the United States

American Journal of Preventive Medicine

Kim DD, Wilde PE, Michaud DS, Liu J, Lizewski L, Onopa J, Mozaffarian D, Zhang FF, Wong JB. Cost Effectiveness of Nutrition Policies on Processed Meat: Implications for Cancer Burden in the U.S. American Journal of Preventive Medicine 2019;57(5).

Putting the costs and benefits of new gene therapies into perspective

Health Affairs Blog

Cohen JT, Chambers JD, Silver M, Lin PJ, Neumann PJ. "Putting the costs and benefits of new gene therapies into perspective," Health Affairs Blog, September 4, 2019.

Yes, improve the US value frameworks, but recognize they are already in prime time

Value in Health

Neumann PJ. Yes, Improve the US Value Frameworks, But Recognize They Are Already in Prime Time. Value in Health 2019;22(9):975–6.

Use of a choice survey to identify adult, adolescent and parent preferences for vaccination in the United States

Journal of Patient-Reported Outcomes

Lavelle TA, Messonnier M, Stokley S, Kim DD, Ramakrishnan A, Gebremariam A, Simon NE, Rose AM, Prosser LA. Use of a choice survey to identify adult, adolescent and parent preferences for vaccination in the United States. Journal of Patient-Reported Outcomes 2019;3(1).

Do interventions promoting medical homes in FQHCs improve continuity of care for Medicare beneficiaries?

Journal of Public Health

Buttorff C, Timbie JW, Lavelle TA, Malsberger R, Kress AM, Setodji CM, Kahn KL . Do interventions promoting medical homes in FQHCs improve continuity of care for Medicare beneficiaries? Journal of Public Health 2019;:1–13.

Healthcare costs and opioid use associated with high-impact chronic spinal pain in the United States

The Spine Journal

Herman PM, Broten N, Lavelle TA, Sorbero ME, Coulter ID. Healthcare costs and opioid use associated with high-impact chronic spinal pain in the United States. Spine 2019 (in press).

Exploring the prevalence and construct validity of high-impact chronic pain across chronic low-back pain study samples

The Spine Journal

Herman PM, Broten N, Lavelle TA, Sorbero ME, Coulter ID. Exploring the prevalence and construct validity of high-impact chronic pain across chronic low-back pain study samples. The Spine Journal 2019 (in press).

Analytic considerations in applying a general economic evaluation reference case to gene therapy

Value in Health

Drummond MF, Neumann PJ, Sullivan SD, Fricke FU, Tunis S, Dabbous O, Toumi M. Analytic considerations in applying a general economic evaluation reference case to gene therapy. Value in Health 2019 (in press).

Taking stock of cost-effectiveness analysis of healthcare in China

BMJ Global Health

Butt T, Liu GG, Kim DD, Neumann PJ. Taking stock of cost-effectiveness analysis of healthcare in China. BMJ Global Health 2019;4(3):1–9.

Publication of decision model source code: Attitudes of health economics authors

PharmacoEconomics

Emerson J, Bacon R, Kent A, Neumann PJ, Cohen JT. Publication of decision model source code: Attitudes of health economics authors. PharmacoEconomics 2019;:1–2.

Adherence to the iDSI reference case among published cost-per-DALY averted studies

PLoS ONE

Emerson J, Panzer A, Cohen JT, Chalkidou K, Teerawattananon Y, Sculpher M, Wilkinson T, Walker D, Neumann PJ, Kim DD. (2019) Adherence to the iDSI reference case among published cost-per-DALY averted studies. PLoS ONE 14(5): e0205633.